Brendan Limone - Concepedia

Author

Brendan Limone

University of Connecticut ORCID

Also Known As

B Limone, B. Limone, B.L. Limone, Brendan L Limone, Brendan L. Limone, Brendan Limone, Craig I. Coleman

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Connecticut Hartford Hospital IBM (United States)Hartford Financial Services (United States)Vertex Pharmaceuticals (United States)

About

Brendan Limone is an author at University of Connecticut specializing in medicine, pharmacotherapy, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	59
2	Emergency Medicine	2	2	43
3	Hematology	2	2	43
4	Anesthesiology	2	2	34
5	Cardiology	2	2	41

Brendan Limone

Publications

310

Citations

H-Index

Page 1

	Year	Citations
Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States Lung‐I Cheng, Emily Durden, Brendan Limone, Journal of Managed Care & Specialty Pharmacy	2015	46
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States Soyon Lee, Daniel C. Baxter, Brendan Limone, Journal of Medical Economics	2012	41
The burden of cystic fibrosis in the Medicaid population Mariam Hassan, Machaon Bonafede, Brendan Limone, ClinicoEconomics and Outcomes Research	2018	30
Cost-Effectiveness of Universal and Platelet Reactivity Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome Craig I Coleman, Brendan Limone The American Journal of Cardiology ThrombosisCardiovascular DiseaseBlood PlateletHematologyAcute Coronary Syndrome	2013	25
Healthcare resource utilization and costs among children with cystic fibrosis in the United States Teja Thorat, Lisa J. McGarry, Machaon Bonafede, Pediatric Pulmonology	2021	21
Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020 Jason R. Gantenberg, Robertus van Aalst, Nicole M. Zimmerman, The Journal of Infectious Diseases	2022	21
Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients Brendan Limone, Matthew Sidovar, Craig I Coleman Health and Quality of Life Outcomes	2013	19
Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism Craig I Coleman, Brendan Limone, Brahim Bookhart, Thrombosis Research ThrombosisPulmonary EmbolismVenous ThrombosisCost-effectiveness AnalysisExtended Duration Anticoagulation	2014	18
Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis Ellison Suthoff, Mac Bonafede, Brendan Limone, Journal of Medical Economics	2016	17
Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA Christopher F. Bell, Julie Priest, Marni Stott‐Miller, Lupus Science & Medicine	2020	17

Page 1